Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age.
Dhruv PuriChest Indrawing Pneumonia Management Cipam Study GroupAntoinette TshefuAdrien Lokangaka LongombeFabian EsamaiIrene MareteAdejumoke Idowu AyedeEbunoluwa A AdejuyigbeRobinson D WammandaShamim Ahmad QaziRajiv BahlPublished in: PloS one (2021)
The trial was registered with Australian New Zealand Clinical Trials Registry under ID ACTRN 12610000286044.